Mode
Text Size
Log in / Sign up
N/A N=100 Randomized Single-blind Other

Self-Control in Bulimia Nervosa

Bulimia Nervosa

Enrolled (actual)
100
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: Brain Activation Associated With P(Stop) — 0.02; 0.11; 0.04; 0.05 BOLD Signal

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
fasting state (Other); fed state (Other); magnetic resonance imaging (Other)
Age
Adult · 18+ yrs
Sex
Female
Sponsor
Icahn School of Medicine at Mount Sinai
Primary completion
Nov 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Brain Activation Associated With P(Stop)
0.02; 0.11; 0.04; 0.05; -0.16; -0.06
PRIMARY
Brain Activation Associated With Prediction Errors (Unsigned)
0.09; 0.13; 0.08; 0.09; 0.07; 0.11
PRIMARY
Brain Activation Associated With Prediction Errors (Signed)
0.05; 0.07; 0.03; 0.02; 0.16; 0.16
PRIMARY
Brain Activation Associated With Successful Inhibition
0.06; 0.11; 0.08; 0.06; 0.18; 0.21
SECONDARY
Stop Signal Reaction Time (SSRT)
164.37; 151.70; 170.80; 166.58
SECONDARY
Stop Signal Task Inhibition
57.29; 55.56; 53.12; 56.25

Summary

This study examines the influence of acute fasting and eating on self-control in adult females with and without bulimia nervosa (BN). Specifically, the study team is investigating whether differences in behavior and brain activation in response to computer tasks after fasting and after eating a meal could help to explain the symptoms of bulimia nervosa. Data will be collected using questionnaires and a technology called magnetic resonance imaging (MRI).

Eligibility Criteria

Inclusion Criteria

  • Female
  • Aged 18 to 35 years
  • Currently between 85 and 130% of the expected weight for height
  • Right-handed
  • English-speaking

Additional Inclusion Criteria for Women with Bulimia Nervosa:

  • Meet DSM-5 criteria for bulimia nervosa

Exclusion Criteria

  • Medical instability
  • Ongoing medical treatment, medical condition, or psychiatric disorder that may interfere with study variables or participation
  • Shift work
  • Pregnancy, planned pregnancy, or lactation during the study period
  • Allergy to any of the ingredients in or unwillingness to consume the standardized meal or unwillingness to drink water during the fasting period
  • Any contraindication for fMRI
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04409457). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search